{"retracted":false,"update":{"timestamp":1412121600000,"doi":"10.1016/j.schres.2014.07.035","type":"err"},"doi":"10.1016/j.schres.2014.05.040","journal":"Schizophrenia Research","publisher":"Elsevier BV","title":"Corrigendum to “Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial” [Schizophr. Res. 157 (1–3) (August 2014) 112–119]"}
